Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54M
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
55.5M
-
Shares change
-
-4.89M
-
Total reported value, excl. options
-
$183M
-
Value change
-
-$14.2M
-
Put/Call ratio
-
0.1
-
Number of buys
-
41
-
Number of sells
-
-73
-
Price
-
$3.30
Significant Holders of Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share (FULC) as of Q2 2023
134 filings reported holding FULC - Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q2 2023.
Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share (FULC) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.5M shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (11.6M shares), RTW INVESTMENTS, LP (6.06M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (5.72M shares), FMR LLC (5.55M shares), COWEN AND COMPANY, LLC (3.12M shares), VANGUARD GROUP INC (2.63M shares), TRV GP IV, LLC (2.34M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.31M shares), Point72 Asset Management, L.P. (1.9M shares), and BlackRock Inc. (1.51M shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.